Skip to main content

Table 1 Schedule of data collection

From: Three-day regimen of oseltamivir for post-exposure prophylaxis of influenza in hospital wards: a study protocol for a prospective, multi-center, single-arm trial

  Before PEPa Observation period
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
Informed consent X        
Clinical assessmentb X        
Laboratory testc X        
PEPa   X X X     
Fever   X X X X X X X
Respiratory symptomsd   X X X X X X X
Immunochromatographic testinge   X X X X X X X
Adverse events   X X X X X X X
  1. aPost-exposure prophylaxis
  2. bClinical assessment: history including age, sex, body weight, influenza vaccination, past infection with influenza, underlying disease and medical history
  3. cLaboratory test: hemoglobin, white blood count, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and creatinine
  4. dRespiratory symptoms: cough or sneezing
  5. eIf the close contacts with index patients with influenza have fever or respiratory symptoms within 7 days after PEP, immunochromatographic testing of influenza will be carried out